Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Complete Response Letter
Biotech
Milestone resubmits NDA, Aldeyra readies 2nd chance filing
Milestone Pharmaceuticals has resubmitted a new drug application to the FDA, with Aldeyra readying a similar ask for the second half of the year.
Max Bayer
Mar 28, 2024 10:40am
FDA blocks approval of Regeneron's blood cancer drug
Mar 25, 2024 9:25pm
Minerva's schizophrenia drug rejected by FDA for 2nd time
Feb 27, 2024 9:34am
Aldeyra forewarns potential FDA rejection for dry eye med
Oct 16, 2023 2:49pm
Second layoff wave hits ImmunityBio in less than a year
Sep 22, 2023 11:22am
Galera lays off 70% as radiotherapy complication drug rejected
Aug 10, 2023 8:19am